Elite in Thymic Epithelial Tumor

Paolo A. Zucali

Via Manzoni 56, Rozzano, 
Milan, IT 
Elite in Thymic Epithelial Tumor
Via Manzoni 56, Rozzano, 
Milan, IT 
OverviewLocationsClinical Research

Overview

Paolo Zucali practices in Milan, Italy. Mr. Zucali is rated as an Elite expert by MediFind in the treatment of Thymic Epithelial Tumor. His top areas of expertise are Mesothelioma, Thymic Epithelial Tumor, Renal Cell Carcinoma (RCC), Nephrectomy, and Cystectomy.

His clinical research consists of co-authoring 145 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 25 articles in the study of Thymic Epithelial Tumor.

Gender
Male

Locations

Via Manzoni 56, Rozzano, Milan, 20089, Italy
Other Locations
Pieve Emanuele, Italy
Via Manzoni 56, Rozzano, 20089, Italy
Italiana, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Pharmacogenetics of Vinorelbine in Malignant Pleural Mesothelioma Patient
Pharmacogenetics of Vinorelbine in Malignant Pleural Mesothelioma Patient
Enrollment Status: Completed
Publish Date: September 10, 2022
Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma. A Multicenter, Single-arm Phase II Trial
Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma. A Multicenter, Single-arm Phase II Trial
Enrollment Status: Completed
Publish Date: July 14, 2021
Intervention Type: Drug
Study Drug: Lurbinectedin
Study Phase: Phase 2
ATREUS Trial - A Phase II Study on the Activity of Trabectedin of Pretreated Epithelioid or Biphasic / Sarcomatoid Malignant Pleural Mesothelioma(MPM)
ATREUS Trial - A Phase II Study on the Activity of Trabectedin of Pretreated Epithelioid or Biphasic / Sarcomatoid Malignant Pleural Mesothelioma(MPM)
Enrollment Status: Completed
Publish Date: January 23, 2020
Intervention Type: Drug
Study Phase: Phase 2
NGR019: Randomized Double-blind Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced Malignant Pleural Mesothelioma (MPM)
NGR019: Randomized Double-blind Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced Malignant Pleural Mesothelioma (MPM)
Enrollment Status: Completed
Publish Date: January 15, 2019
Intervention Type: Drug, Other
Study Phase: Phase 2
View 3 Less Clinical Trials

145 Total Publications

Perioperative Treatments in Pleural Mesothelioma: State of the Art and Future Directions.
Perioperative Treatments in Pleural Mesothelioma: State of the Art and Future Directions.
Journal: Cancers
Published: September 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Zucali's expertise for a condition
ConditionClose
View All 23 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile